Optimizing ribavirin dosage: a new challenge to improve treatment efficacy in genotype 1 hepatitis C patients - Loustaud-Ratti, V; Stanke-Labesque, F; Marquet, P; Gagnieu, MC; Maynard, M; Babany, G (Gastroenterol Clin Biol., 2009)
et al.